Donald Mcmillan
Concepts (235)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Discrimination Learning | 24 | 2011 | 64 | 3.870 |
Why?
| Reinforcement Schedule | 25 | 2011 | 78 | 2.940 |
Why?
| Pentobarbital | 24 | 2009 | 28 | 2.340 |
Why?
| Behavior, Animal | 16 | 2015 | 181 | 2.020 |
Why?
| Conditioning, Operant | 20 | 2008 | 116 | 1.650 |
Why?
| Phencyclidine | 19 | 2009 | 38 | 1.610 |
Why?
| Methamphetamine | 17 | 2015 | 200 | 1.540 |
Why?
| Columbidae | 32 | 2011 | 53 | 1.500 |
Why?
| Central Nervous System Stimulants | 15 | 2009 | 213 | 1.280 |
Why?
| Central Nervous System Depressants | 8 | 2009 | 79 | 1.230 |
Why?
| Dose-Response Relationship, Drug | 34 | 2011 | 1376 | 1.130 |
Why?
| Motivation | 11 | 2005 | 273 | 0.960 |
Why?
| Alcohol Drinking | 8 | 2001 | 224 | 0.930 |
Why?
| Ethanol | 8 | 2009 | 340 | 0.880 |
Why?
| Morphine | 11 | 2011 | 103 | 0.830 |
Why?
| Animals | 64 | 2015 | 13187 | 0.800 |
Why?
| Methadone | 3 | 2011 | 172 | 0.740 |
Why?
| Nicotine | 6 | 2005 | 187 | 0.680 |
Why?
| Smoking | 5 | 2011 | 511 | 0.680 |
Why?
| Hypnotics and Sedatives | 9 | 2002 | 75 | 0.630 |
Why?
| Anti-Anxiety Agents | 4 | 2008 | 35 | 0.630 |
Why?
| Punishment | 4 | 2008 | 22 | 0.630 |
Why?
| Male | 64 | 2015 | 25241 | 0.580 |
Why?
| Chlordiazepoxide | 6 | 2003 | 8 | 0.560 |
Why?
| Opioid-Related Disorders | 3 | 2011 | 381 | 0.540 |
Why?
| Antibodies, Monoclonal | 3 | 2006 | 459 | 0.530 |
Why?
| Substance Abuse Treatment Centers | 3 | 2011 | 76 | 0.520 |
Why?
| Rats | 25 | 2015 | 3305 | 0.520 |
Why?
| Substance-Related Disorders | 8 | 2011 | 600 | 0.500 |
Why?
| Cocaine-Related Disorders | 3 | 2005 | 205 | 0.490 |
Why?
| Reaction Time | 6 | 2009 | 216 | 0.470 |
Why?
| Nicotinic Agonists | 3 | 2005 | 56 | 0.460 |
Why?
| Cocaine | 5 | 2003 | 170 | 0.460 |
Why?
| Dextroamphetamine | 7 | 2003 | 39 | 0.450 |
Why?
| Time Perception | 3 | 2000 | 29 | 0.420 |
Why?
| Dizocilpine Maleate | 3 | 2009 | 15 | 0.400 |
Why?
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2011 | 4 | 0.400 |
Why?
| Smoking Cessation | 2 | 2005 | 299 | 0.400 |
Why?
| Generalization, Stimulus | 3 | 1999 | 5 | 0.400 |
Why?
| Excitatory Amino Acid Antagonists | 2 | 2009 | 51 | 0.390 |
Why?
| GABA Modulators | 2 | 2009 | 9 | 0.380 |
Why?
| Narcotics | 5 | 2002 | 111 | 0.380 |
Why?
| Rats, Sprague-Dawley | 14 | 2015 | 1597 | 0.380 |
Why?
| Impulsive Behavior | 1 | 2011 | 77 | 0.370 |
Why?
| Reward | 1 | 2011 | 110 | 0.370 |
Why?
| Psychotropic Drugs | 4 | 1997 | 77 | 0.350 |
Why?
| Amphetamine | 3 | 2008 | 38 | 0.350 |
Why?
| Drug Interactions | 8 | 2009 | 206 | 0.340 |
Why?
| Self Administration | 4 | 2015 | 102 | 0.330 |
Why?
| Learning | 2 | 2006 | 158 | 0.320 |
Why?
| Carbon Monoxide | 2 | 2005 | 40 | 0.320 |
Why?
| Choice Behavior | 2 | 2009 | 85 | 0.320 |
Why?
| Trimethyltin Compounds | 4 | 1995 | 5 | 0.320 |
Why?
| Disease Progression | 1 | 2011 | 825 | 0.310 |
Why?
| Sodium Oxybate | 1 | 2008 | 11 | 0.310 |
Why?
| Analgesics, Opioid | 2 | 2011 | 552 | 0.300 |
Why?
| Arousal | 3 | 2005 | 98 | 0.280 |
Why?
| Drinking | 3 | 1995 | 38 | 0.270 |
Why?
| Central Nervous System Agents | 1 | 2006 | 11 | 0.270 |
Why?
| Eating | 3 | 1995 | 162 | 0.250 |
Why?
| Behavior | 2 | 1999 | 45 | 0.240 |
Why?
| Adrenergic Agents | 1 | 2004 | 15 | 0.240 |
Why?
| Sodium Chloride | 2 | 2011 | 57 | 0.230 |
Why?
| Antibodies, Blocking | 1 | 2002 | 8 | 0.210 |
Why?
| Time Factors | 8 | 2011 | 2903 | 0.210 |
Why?
| Diazepam | 4 | 1997 | 17 | 0.210 |
Why?
| Haloperidol | 5 | 1996 | 46 | 0.210 |
Why?
| Hallucinogens | 2 | 2000 | 62 | 0.210 |
Why?
| Organometallic Compounds | 2 | 1999 | 44 | 0.200 |
Why?
| Appetitive Behavior | 3 | 1997 | 3 | 0.200 |
Why?
| Perception | 1 | 2002 | 116 | 0.200 |
Why?
| Drug Combinations | 3 | 2009 | 123 | 0.200 |
Why?
| Rats, Inbred Strains | 7 | 1999 | 196 | 0.190 |
Why?
| Genotype | 1 | 2001 | 537 | 0.180 |
Why?
| Species Specificity | 6 | 2002 | 192 | 0.170 |
Why?
| Substance Withdrawal Syndrome | 3 | 1996 | 169 | 0.170 |
Why?
| Tobacco Use Disorder | 2 | 1998 | 168 | 0.170 |
Why?
| Manganese Poisoning | 1 | 1999 | 5 | 0.170 |
Why?
| Trialkyltin Compounds | 2 | 1989 | 2 | 0.160 |
Why?
| Menthol | 1 | 1998 | 17 | 0.160 |
Why?
| Adult | 11 | 2011 | 13236 | 0.160 |
Why?
| Nervous System Diseases | 1 | 1999 | 88 | 0.150 |
Why?
| Parkinson Disease | 1 | 1999 | 154 | 0.140 |
Why?
| Phenobarbital | 1 | 1996 | 17 | 0.140 |
Why?
| Hydromorphone | 1 | 1996 | 15 | 0.140 |
Why?
| Receptors, sigma | 2 | 1993 | 16 | 0.130 |
Why?
| Physical Exertion | 1 | 1995 | 44 | 0.130 |
Why?
| Behavior, Addictive | 2 | 2011 | 58 | 0.130 |
Why?
| Serial Learning | 2 | 1989 | 4 | 0.130 |
Why?
| Psychomotor Performance | 3 | 2002 | 130 | 0.130 |
Why?
| Pain Measurement | 1 | 1996 | 240 | 0.120 |
Why?
| Female | 12 | 2015 | 26472 | 0.120 |
Why?
| Receptors, Neurotransmitter | 2 | 1991 | 16 | 0.120 |
Why?
| Electroshock | 3 | 2008 | 10 | 0.120 |
Why?
| Injections, Intramuscular | 4 | 2008 | 54 | 0.120 |
Why?
| Middle Aged | 9 | 2011 | 12069 | 0.110 |
Why?
| Emetics | 1 | 1993 | 2 | 0.110 |
Why?
| Substance Abuse Detection | 2 | 1996 | 92 | 0.110 |
Why?
| Guanidines | 1 | 1993 | 31 | 0.110 |
Why?
| Antiemetics | 1 | 1993 | 32 | 0.110 |
Why?
| Phenazocine | 2 | 1991 | 2 | 0.110 |
Why?
| Vomiting | 1 | 1993 | 75 | 0.110 |
Why?
| Antidepressive Agents | 1 | 1994 | 176 | 0.110 |
Why?
| Humans | 19 | 2011 | 49974 | 0.100 |
Why?
| Amphetamines | 2 | 1989 | 29 | 0.100 |
Why?
| Ethylketocyclazocine | 1 | 2011 | 1 | 0.100 |
Why?
| Butorphanol | 1 | 2011 | 6 | 0.100 |
Why?
| Pentazocine | 1 | 2011 | 5 | 0.100 |
Why?
| Receptors, Opioid | 1 | 1991 | 18 | 0.100 |
Why?
| Psychiatric Status Rating Scales | 3 | 2011 | 319 | 0.100 |
Why?
| Intelligence Tests | 1 | 2011 | 44 | 0.100 |
Why?
| Receptors, Opioid, kappa | 1 | 2011 | 39 | 0.100 |
Why?
| Receptors, Opioid, mu | 1 | 2011 | 46 | 0.100 |
Why?
| Urinalysis | 1 | 2011 | 34 | 0.100 |
Why?
| Computers | 1 | 2011 | 47 | 0.100 |
Why?
| Naltrexone | 1 | 2011 | 58 | 0.100 |
Why?
| Narcotic Antagonists | 1 | 2011 | 135 | 0.090 |
Why?
| Toxicology | 1 | 1990 | 28 | 0.090 |
Why?
| Nervous System | 1 | 1990 | 33 | 0.090 |
Why?
| Injections, Intravenous | 3 | 2008 | 140 | 0.090 |
Why?
| Dextrorphan | 1 | 2009 | 1 | 0.090 |
Why?
| Amitriptyline | 1 | 1989 | 13 | 0.090 |
Why?
| Desipramine | 1 | 1989 | 26 | 0.090 |
Why?
| Receptors, GABA-A | 1 | 2009 | 12 | 0.090 |
Why?
| Dextromethorphan | 1 | 2009 | 17 | 0.090 |
Why?
| Stellate Ganglion | 1 | 1989 | 3 | 0.090 |
Why?
| Color Perception | 1 | 1989 | 9 | 0.080 |
Why?
| Generalization, Response | 2 | 1998 | 3 | 0.080 |
Why?
| Arkansas | 4 | 2005 | 1977 | 0.080 |
Why?
| Software | 1 | 2011 | 273 | 0.080 |
Why?
| Apomorphine | 1 | 1988 | 7 | 0.080 |
Why?
| Drug Administration Schedule | 3 | 2000 | 376 | 0.080 |
Why?
| Pharmacology, Clinical | 1 | 1987 | 6 | 0.080 |
Why?
| Posture | 1 | 1988 | 59 | 0.080 |
Why?
| Anesthetics, Local | 2 | 2002 | 75 | 0.080 |
Why?
| Dopamine Uptake Inhibitors | 1 | 2008 | 56 | 0.080 |
Why?
| Central Nervous System | 1 | 1987 | 85 | 0.070 |
Why?
| Education, Medical, Undergraduate | 1 | 1987 | 82 | 0.070 |
Why?
| Dyskinesia, Drug-Induced | 4 | 1990 | 22 | 0.070 |
Why?
| Teaching | 1 | 1987 | 116 | 0.070 |
Why?
| Curriculum | 2 | 1997 | 401 | 0.070 |
Why?
| Buspirone | 2 | 1998 | 4 | 0.070 |
Why?
| Ephedrine | 1 | 2005 | 21 | 0.060 |
Why?
| Administration, Cutaneous | 1 | 2005 | 51 | 0.060 |
Why?
| Students, Medical | 1 | 1987 | 157 | 0.060 |
Why?
| Residential Treatment | 1 | 2005 | 16 | 0.060 |
Why?
| Antipsychotic Agents | 2 | 2002 | 232 | 0.060 |
Why?
| Breath Tests | 1 | 2005 | 39 | 0.060 |
Why?
| Aged | 2 | 2011 | 9310 | 0.060 |
Why?
| Cross-Over Studies | 1 | 2005 | 224 | 0.060 |
Why?
| Women's Health | 1 | 2005 | 90 | 0.060 |
Why?
| Treatment Outcome | 2 | 2005 | 5141 | 0.060 |
Why?
| Analysis of Variance | 1 | 2005 | 562 | 0.060 |
Why?
| Caffeine | 1 | 2003 | 67 | 0.050 |
Why?
| Phenothiazines | 1 | 2002 | 9 | 0.050 |
Why?
| Schizophrenia | 3 | 1989 | 256 | 0.050 |
Why?
| Psychopharmacology | 1 | 2002 | 5 | 0.050 |
Why?
| Injections, Intraperitoneal | 1 | 2002 | 54 | 0.050 |
Why?
| Extinction, Psychological | 1 | 2002 | 33 | 0.050 |
Why?
| Cues | 1 | 2002 | 49 | 0.050 |
Why?
| History, 20th Century | 1 | 2002 | 99 | 0.050 |
Why?
| Mice, Inbred BALB C | 1 | 2002 | 304 | 0.050 |
Why?
| Selection, Genetic | 1 | 2001 | 24 | 0.050 |
Why?
| Young Adult | 1 | 2011 | 3958 | 0.050 |
Why?
| Mental Recall | 1 | 2001 | 58 | 0.050 |
Why?
| Drug Tolerance | 2 | 1992 | 60 | 0.050 |
Why?
| Food | 2 | 1999 | 72 | 0.050 |
Why?
| Receptors, Phencyclidine | 2 | 1991 | 2 | 0.050 |
Why?
| Adolescent | 1 | 2011 | 6356 | 0.040 |
Why?
| Administration, Oral | 1 | 2001 | 426 | 0.040 |
Why?
| Attention | 2 | 1991 | 175 | 0.040 |
Why?
| HLA Antigens | 2 | 1990 | 52 | 0.040 |
Why?
| Manganese | 1 | 1999 | 23 | 0.040 |
Why?
| Orientation | 1 | 1979 | 19 | 0.040 |
Why?
| Serotonin Receptor Agonists | 1 | 1998 | 14 | 0.040 |
Why?
| Tobacco Use Cessation | 1 | 1998 | 8 | 0.040 |
Why?
| Stereoisomerism | 2 | 2008 | 104 | 0.040 |
Why?
| Forecasting | 1 | 1999 | 150 | 0.040 |
Why?
| Nursing Education Research | 1 | 1997 | 35 | 0.040 |
Why?
| Students, Nursing | 1 | 1997 | 56 | 0.030 |
Why?
| Health Education | 1 | 1997 | 156 | 0.030 |
Why?
| Models, Genetic | 1 | 1995 | 170 | 0.030 |
Why?
| Comorbidity | 1 | 1996 | 615 | 0.030 |
Why?
| Conditioning, Classical | 1 | 1994 | 33 | 0.030 |
Why?
| Infusions, Intravenous | 1 | 1993 | 206 | 0.030 |
Why?
| Electrodes, Implanted | 1 | 1992 | 30 | 0.030 |
Why?
| Binding Sites | 1 | 1993 | 374 | 0.030 |
Why?
| Mice | 1 | 2002 | 5739 | 0.030 |
Why?
| Pyrimidines | 1 | 1993 | 192 | 0.020 |
Why?
| Circadian Rhythm | 1 | 1991 | 88 | 0.020 |
Why?
| Follow-Up Studies | 1 | 1996 | 2182 | 0.020 |
Why?
| Models, Neurological | 1 | 1990 | 58 | 0.020 |
Why?
| Mesocricetus | 1 | 1989 | 6 | 0.020 |
Why?
| Cricetinae | 1 | 1989 | 192 | 0.020 |
Why?
| 3,4-Methylenedioxyamphetamine | 1 | 1989 | 2 | 0.020 |
Why?
| Parkinson Disease, Secondary | 1 | 1989 | 7 | 0.020 |
Why?
| Civil Rights | 1 | 1989 | 10 | 0.020 |
Why?
| Action Potentials | 1 | 1989 | 132 | 0.020 |
Why?
| Schizophrenic Psychology | 1 | 1989 | 68 | 0.020 |
Why?
| Brain Chemistry | 1 | 1989 | 70 | 0.020 |
Why?
| Feeding Behavior | 1 | 1990 | 181 | 0.020 |
Why?
| Receptors, Dopamine | 1 | 1988 | 21 | 0.020 |
Why?
| Hydroxylation | 1 | 2008 | 61 | 0.020 |
Why?
| Acoustic Stimulation | 1 | 1988 | 97 | 0.020 |
Why?
| Biotransformation | 1 | 2008 | 86 | 0.020 |
Why?
| Animal Welfare | 1 | 1987 | 7 | 0.020 |
Why?
| Biological Availability | 1 | 2008 | 122 | 0.020 |
Why?
| Structure-Activity Relationship | 1 | 1988 | 395 | 0.020 |
Why?
| Drug Evaluation, Preclinical | 1 | 1987 | 144 | 0.020 |
Why?
| Attitude | 1 | 1987 | 69 | 0.020 |
Why?
| Stereotyped Behavior | 1 | 2007 | 17 | 0.020 |
Why?
| Risk | 1 | 1987 | 320 | 0.020 |
Why?
| Referral and Consultation | 1 | 1989 | 285 | 0.020 |
Why?
| Motor Activity | 1 | 2007 | 229 | 0.020 |
Why?
| Sex Characteristics | 1 | 2007 | 190 | 0.020 |
Why?
| Quality of Life | 1 | 1987 | 836 | 0.010 |
Why?
| Macaca mulatta | 2 | 1989 | 93 | 0.010 |
Why?
| United States | 1 | 1989 | 4860 | 0.010 |
Why?
| Program Evaluation | 1 | 1997 | 354 | 0.010 |
Why?
| Research Design | 1 | 1997 | 344 | 0.010 |
Why?
| Databases, Factual | 1 | 1997 | 658 | 0.010 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 1997 | 488 | 0.010 |
Why?
| HLA-DR4 Antigen | 1 | 1990 | 2 | 0.010 |
Why?
| p-Chloroamphetamine | 1 | 1989 | 3 | 0.010 |
Why?
| beta-Endorphin | 1 | 1989 | 7 | 0.010 |
Why?
| Radioimmunoassay | 1 | 1989 | 44 | 0.010 |
Why?
| Biogenic Monoamines | 1 | 1989 | 13 | 0.010 |
Why?
| Neurologic Examination | 1 | 1989 | 77 | 0.010 |
Why?
| Radioligand Assay | 1 | 1988 | 46 | 0.010 |
Why?
| Dopamine Antagonists | 1 | 1988 | 20 | 0.010 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 1989 | 38 | 0.000 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1988 | 349 | 0.000 |
Why?
| Sex Factors | 1 | 1989 | 691 | 0.000 |
Why?
| Hospitalization | 1 | 1989 | 652 | 0.000 |
Why?
| Risk Factors | 1 | 1989 | 3613 | 0.000 |
Why?
|
|
Mcmillan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|